Quick Answer
ZIMMER BIOMET HOLDINGS, INC. reported Revenue (ASC 606) of $8.23 billion for fiscal year 2025.
ZIMMER BIOMET HOLDINGS, INC. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $8.23B | +7.2% |
| 2024 | $7.68B | +3.8% |
| 2023 | $7.39B | +6.5% |
| 2022 | $6.94B | +1.6% |
| 2021 | $6.83B | +11.4% |
| 2020 | $6.13B | -23.2% |
| 2019 | $7.98B | +0.6% |
| 2018 | $7.93B | +1.7% |
| 2017 | $7.80B | +1.8% |
| 2016 | $7.67B | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.00B | +9.7% | -3.7% |
| June 30, 2025 | $2.08B | +7.0% | +8.8% |
| March 31, 2025 | $1.91B | +1.1% | +4.7% |
| September 30, 2024 | $1.82B | +4.0% | -6.1% |
| June 30, 2024 | $1.94B | +3.9% | +2.8% |
| March 31, 2024 | $1.89B | +3.2% | +7.7% |
| September 30, 2023 | $1.75B | +5.0% | -6.2% |
| June 30, 2023 | $1.87B | +4.9% | +2.1% |
- ZIMMER BIOMET HOLDINGS, INC. showed an increase of +7.2% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2025 period, ZIMMER BIOMET HOLDINGS, INC.’s revenue (asc 606) has grown by 7.3% (from $7.67 billion to $8.23 billion).
- The most recent figure is from ZIMMER BIOMET HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: